Payer Mix and Reimbursement Mechanics for Dermatology Practice Owners

Executive summary

Payer mix is a revenue model, a capacity plan and a source of operating risk. The familiar percentage split between Medicare, commercial insurance and self-pay gives owners a starting point, but it does not describe the work or the cash produced by each segment. A practice with a large Medicare share may depend on office evaluation and management visits, biopsies, destruction, excisions, Mohs surgery or pathology in very different proportions. A commercial contract with a nominally higher fee schedule can still underperform if its allowed amounts are narrow, its authorization rules consume staff time, or its patients leave substantial balances uncollected.

The Medicare Physician Fee Schedule (MPFS) provides a useful reference because its payment logic is public. CMS assigns relative value units (RVUs) to services, adjusts the work, practice expense and malpractice components for local costs, and applies a conversion factor. The resulting allowed amount is not a clinic's margin. Staffing, room turnover, supplies, equipment, pathology arrangements and denials all affect contribution, as do patient cost sharing and billing labor.

For owners, the practical task is to connect payer along with service and provider data. Reconcile billed services and allowed amounts to remittances; identify contract terms by code family; separate professional and technical components; and measure net collections and direct costs by service line. Review changes in the MPFS and commercial contracts as changes to a defined set of services, not as a single practice-wide percentage. The figures below are context, not forecasts or targets.

Key figures

Analysis

1. Turn payer mix into a revenue map

Start with paid claims or remittance data, not charges. For each payer, calculate a share of net collections over a defined service-date period. Then repeat the calculation by code family and provider type. A top-line mix of 45% Medicare, 40% commercial and 15% patient-pay can hide that Medicare is concentrated in Mohs, while commercial collections come mainly from office visits and biopsies. Those are different exposures to fee updates, staffing demands and patient cost sharing.

Keep three views side by side: share of encounters, share of allowed revenue and share of collected cash. Encounter share shows workload. Allowed revenue shows contractual pricing before collection performance. Cash share reflects actual deposits but can lag service dates. A payer that represents 30% of visits and 20% of cash may have lower allowed amounts, weaker realization, a different service mix or simply slower remittance. The categories should be tested before an owner concludes that a contract is poor.

Use a service-line crosswalk that groups individual codes into meaningful work: office E/M, biopsy and specimen handling along with benign and malignant destruction along with excision and repair, Mohs along with pathology and other services. Preserve the code-level detail underneath each category. If a code set or grouping changes, document it so that a trend is not mistaken for a reimbursement change. Where patient responsibility is material, report the amount billed, amount collected and aging separately.

2. Read the MPFS as a formula, not a price list

CMS values a service through relative resources. In simplified form, it combines work RVUs, practice expense RVUs and malpractice RVUs, adjusts those components by geographic practice cost indexes, and multiplies the result by a conversion factor. Payment policy indicators and modifiers can affect the final result. This structure explains why two codes with similar clinical labels may have different payments and why the same code can produce different Medicare amounts in different localities.

An RVU is not a dollar amount, and a national payment figure is not necessarily the amount paid in a particular practice. Owners should use the official fee schedule lookup or current downloadable files for the locality, date of service, place of service and applicable modifiers. Check whether the service is priced under the physician fee schedule, a separate laboratory or pathology schedule, or another payment system. When a service is performed in a facility, the professional payment may differ from the office setting because the practice expense is treated differently.

The MPFS conversion factor is subject to rulemaking and legislation. A percentage update applied to the factor does not mean every dermatology code changes by that same percentage. Relative values, budget neutrality, policy adjustments, locality factors and code-specific edits interact. For owner planning, the sound unit is a weighted basket of the codes the practice actually bills. Calculate the modeled change using its own prior-period volume, then show volume and mix separately from price.

3. E/M economics depend on documentation and schedule design

Office evaluation and management services carry work and practice expense values, but their realized revenue depends on accurate code selection and the distribution of visit levels. Medical decision making or qualifying time supports the selected level under applicable coding rules. A practice should not set a target level mix and ask clinicians to fit documentation to it. Instead, review a representative set of claims, identify recurring documentation gaps, and correct the workflow or education that produced them.

Owners can make E/M performance visible without turning coding into a volume contest. Track visits by code, clinician along with payer and place of service, then pair the distribution with denial rates, audit findings, visit duration and follow-up work. A change in average allowed amount may reflect a shift toward complex visits, a new payer, revised coding, a contract amendment or an error. Ask the billing lead to reconcile code-level allowed amounts against the contract and remittance advice before attributing the change to provider behavior.

When a separately identifiable E/M service occurs on the same date as a procedure along with modifier and documentation rules matter. The practice needs a consistent process for determining whether the E/M work is distinct and supported. Do not make the decision solely by comparing the expected payment with the time spent. A compliance review can identify patterns where staff routinely append a modifier, omit it, or lack a clear record of the separate work.

4. Biopsies and destructions need separate cost views

Biopsy revenue can include a professional service and, depending on the practice's arrangements, pathology work. Those components may be billed by different entities and paid under separate rules. A practice that collects the biopsy charge but sends the specimen to an outside laboratory has a different margin from one that performs its own pathology services. Map who bills each component, who supplies the materials, who handles results and follow-up, and who bears the cost of rework or rejected specimens.

The Medicare trend study reported rising inflation-adjusted reimbursement for biopsy and shave removal over its historical observation window, while destruction reimbursement moved in the opposite direction. That comparison is useful because it rejects the idea that every dermatology procedure follows one payment curve. It does not establish today's local margin: labor, supply expense, code mix and commercial terms may have changed independently. Use current locality files and actual remittances for any financial decision.

Destruction can encompass multiple code families and lesion counts, with rules that depend on the specific service and payer. Build a code-level edit list that checks units, diagnosis links along with site and modifier requirements. For each payer, compare billed claims with allowed units and denial reasons. An unexpectedly low payment may be correct under the contract, the result of a bundling edit, or a coding defect. A claim sample and its explanation of benefits usually reveal which one.

5. Mohs revenue combines physician work along with pathology and capacity

Mohs production is driven by stages and tissue blocks, the applicable code structure, the professional work and the practice expense of maintaining an efficient surgical workflow. The financial model should include physician time, histotechnologist and support staffing, laboratory consumables, equipment maintenance, room use, specimen processing and downstream repair work where performed. A high allowed amount per case can coexist with a narrow margin if stage volume, staffing or rework is higher than expected.

Clarify the billing arrangement for each component. In some organizations, the same entity bills the surgery and pathology; in others, ownership, employment or laboratory arrangements split the revenue and expense. Confirm who bills the professional and technical components, how pathology is reported, and whether a payer contract addresses each component. Avoid counting a pathology receipt as practice revenue if it belongs to a separate entity or is offset by an intercompany charge.

The historical Medicare data show Mohs as a substantial category of dermatologist payments, but national averages cannot determine whether a particular surgeon's day is profitable. Measure completed cases, stages, blocks, room time, staffing hours, cancellation rate and net collected revenue per session. Compare these measures across comparable sessions and include repair mix where relevant. A change in average reimbursement per case can result from stage mix even when the fee schedule is unchanged.

6. Pathology arrangements can shift both revenue and liability

Pathology economics deserve their own ledger. Identify whether the practice, an affiliated laboratory or an outside group furnishes and bills the service. Reconcile technical and professional components, payer enrollment, specimen volume, supply charges and payments. Verify that the contract and operational arrangement match the entity on the claim. An unclear arrangement can produce duplicate billing, missed revenue, inconsistent patient statements or a compliance concern.

An in-house laboratory requires fixed and variable expense review. Staff coverage, equipment, quality systems, maintenance along with supplies and unused capacity all affect cost per specimen. Outsourcing can replace fixed cost with a contracted price, but may add shipping, turnaround coordination or revenue-sharing terms. Compare total cost and service performance using the same specimen cohort. The analysis should not assume that the option with the higher gross receipts creates the greater contribution.

Confirm contract language for laboratory services, including fee schedules, bundling, claim submission, authorization, records requests, payment recoupment and termination. Where several legal entities are involved, have the arrangement reviewed by appropriate counsel and compliance advisers. Owners need a reconciled picture of the cash and obligations, not just a procedure report that labels all pathology payments as one department's production.

7. Commercial contracts reward disciplined code-level analysis

Commercial agreements may use a percentage of Medicare, a proprietary fee schedule, case rates or other payment methods. The benchmark is meaningful only when the agreement identifies the Medicare version, locality, place of service, code status and update mechanism. The phrase percentage of Medicare can leave room for disputes about which schedule year applies, whether add-on codes receive the same factor, and how new or unlisted codes are priced. Put the calculation method into a crosswalk and validate it against paid claims.

Negotiation should begin with a clean baseline. Assemble volume and allowed amounts by payer and code family; remove noncovered along with denied and patient-responsibility amounts from the contract comparison; and separate professional along with facility and laboratory claims. Model proposed rates against the same service basket. Include administrative costs that are specific to the payer, such as authorization time, medical-record production, claim edits and appeal labor. A contract can show a rate increase while net yield declines if those burdens rise.

Prepare a short list of high-impact issues: underpriced high-volume codes, outlier services, unclear bundling, delayed payment, unilateral amendments along with audit and recoupment periods, credentialing requirements, electronic transaction rules and termination notice. Ask for a rate exhibit that can be loaded and tested, not only a narrative promise. Keep the executed agreement, amendments, fee schedules and payer correspondence together. A rate table without the governing terms may be incomplete.

8. Reimbursement trends should be separated from payer mix shifts

Observed revenue per visit can move for several reasons at once. A greater share of Medicare, a different proportion of procedures, a change in stage or lesion counts, a revised contract, a shift in patient cost sharing or slower collections can all change the result. Decompose the variance into volume, service mix, rate along with denial and collection components. A basic model can hold prior-period volume constant to estimate rate effect, then hold rates constant to estimate mix effect. Label the assumptions and reconcile the result to posted cash.

The public trend evidence shows substantial variation across dermatology code families. It is a reminder to avoid applying a single reimbursement inflation assumption to the practice budget. It also has limits: historical Medicare allowed amounts do not capture commercial contract behavior, local cost inflation, physician productivity or practice-level operating expense. For a budget, build a local basket from current allowed rates and actual service counts, then run low along with base and high volume scenarios. Mark all modeled numbers as illustrative.

Monitor payer changes through operational signals as well as fee schedules. Rising authorization touches, denial rates, days in accounts receivable, partial payments and patient balances can erode yield before a headline rate change becomes visible. Assign a person to each payer's escalation path, and make appeals time-bound. A contract that remains nominally attractive may no longer fit if repeated administrative work consumes scarce staff capacity.

Owner implications

The owner decision is not whether Medicare or commercial insurance is inherently preferable. It is whether each payer's combination of rates, service mix, patient responsibility, administrative burden and collection reliability fits the practice's capacity and capital plan. A payer with lower net collections can still support access or fill capacity; a higher paying payer may require more authorization work, longer visits or specialized staffing. Compare contribution and operational fit before changing participation or scheduling.

Create one monthly view that reconciles encounter volume, allowed amounts, expected patient responsibility, cash along with denials and direct expense by payer and service family. Use service date cohorts where possible, identify posting lag, and label any estimate. Review the largest variances with the billing and clinical operations leads. If the data do not support a conclusion, assign a targeted claim audit or contract review before changing the operating model.

Action checklist

• Define payer categories and keep the definitions stable across reporting periods.
• Report payer share by encounters, allowed revenue and collected cash.
• Build a code crosswalk for E/M, biopsy, destruction, excision along with Mohs and pathology.
• Download the applicable CMS schedule and locality data for the codes billed.
• Reconcile representative claims to contract terms and remittance advice.
• Separate professional and technical pathology components by billing entity.
• Calculate net collection rate by payer using a stated denominator.
• Track denial causes, appeal recovery, patient balances and administrative touches.
• Model fee changes against the practice's actual code volume and service mix.
• Review high-impact commercial contract provisions and retain executed exhibits.
• Label projections and scenario values as illustrative.
• Assign an owner and review date to each unresolved reimbursement variance.

Sources

• CMS, Physician Fee Schedule Documentation and Files
• CMS, Physician Fee Schedule payment mechanics
• CMS, Physician Fee Schedule lookup guide
• American Medical Association, Physician Practice Benchmark Survey
• JAMA Dermatology, Inflation-Adjusted Trends in Medicare Reimbursement for Common Dermatologic Procedures
• JAMA Dermatology, Medicare Payments to Dermatologists
• JAMA Network Open, Use of Skin Cancer Procedures, Medicare Reimbursement, and Overall Expenditures

Scope and limitations

This paper addresses practice finance and reimbursement operations in the United States. Public figures describe the populations along with codes and periods in their source publications; historical rates are not current fee quotes. Medicare payment depends on code, locality, setting along with modifiers and applicable policy. Commercial terms are contract-specific and may not follow Medicare changes. The discussion is educational and does not replace review of a practice's contracts, claims, coding policies or legal obligations. No clinical or patient advice is provided.

Questions? Contact Richard@DoctorsInvestorClub.com.

Education only. This material is for general educational purposes and is not medical, legal, financial, investment, coding, billing or other professional advice. It does not provide clinical or patient guidance.

Related resources

• Owner Resource Library
• Practice valuation calculator
• Owner guides